Thomas I H Dubin insider trades

Open-market stock purchases and sales by Thomas I H Dubin, Director at Intensity Therapeutics, Inc, from SEC Form 4 filings since Jan 11, 2010.

Recent trades

DateStockTradeValue
Jul 16, 2026INTS Intensity Therapeutics, IncBought (not open market)—

Companies traded

  • INTS Intensity Therapeutics, Inc: other filings, last Jul 16, 2026
  • NTBL Notable Labs, Ltd: other filings, last May 8, 2024
  • ALXN Alexion Pharmaceuticals Inc: 38 sales, last Aug 23, 2012

Get free alerts when Thomas I H Dubin files a new trade →